Article Details

Leerink Partners Keeps a Buy Rating on Viking Therapeutics (VKTX)

Retrieved on: 2021-05-03 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Leerink Partners Keeps a Buy Rating on Viking Therapeutics (VKTX). View article details on HISWAI: https://www.smarteranalyst.com/new-blurbs/leerink-partners-keeps-a-buy-rating-on-viking-therapeutics-vktx/

Excerpt

Smith covers the Healthcare sector, focusing on stocks such as Connect Biopharma Holdings, Madrigal Pharmaceuticals, and Eledon Pharmaceuticals.

Article found on: www.smarteranalyst.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up